Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
February 2, 2026: Gastroparesis is Most Common Injury in Lawsuits Against Ozempic and Other GLP-1 Drugs According to court documents, gastroparesis is the most frequently listed injury in complaints filed as part of the GLP-1 product liability litigation (MDL -3094), which includes Ozempic claims
Revised Aug 1 2020
Through Gala GLP-1, you can access GLP-1 weight loss medications (not-FDA approved) starting at just $199 per month (with a 3-month plan)
WhatsApp Support Have questions before booking
US$ 22.65
US$ 27.80
US$ 27.52
US$ 20.15
US$ 23.70
